| Product Code: ETC13230729 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Angioedema Market was valued at USD 0.35 Billion in 2024 and is expected to reach USD 0.65 Billion by 2031, growing at a compound annual growth rate of 10.40% during the forecast period (2025-2031).
The Global Angioedema Market is experiencing steady growth due to factors such as increasing prevalence of angioedema, rising awareness about the condition, advancements in diagnostic techniques, and the introduction of novel treatment options. Angioedema is a potentially life-threatening condition characterized by rapid swelling in the deeper layers of the skin and mucous membranes. The market is driven by the demand for effective medications such as antihistamines, corticosteroids, and novel therapies like bradykinin receptor antagonists. Additionally, the market is witnessing growth in research and development activities focused on developing targeted therapies and personalized treatment approaches. Geographically, North America and Europe dominate the global market due to the high prevalence of angioedema cases and well-established healthcare infrastructure. Overall, the Global Angioedema Market is expected to continue expanding in the coming years.
The Global Angioedema Market is experiencing significant growth due to factors such as increasing prevalence of angioedema, advancements in diagnostic technologies, and rising awareness among healthcare professionals and patients. The market is witnessing a shift towards innovative treatment options, including targeted therapies and biologic drugs, which are expected to drive market growth in the coming years. Additionally, the rising investments in research and development activities by key market players to develop novel treatment options are creating opportunities for market expansion. With the increasing focus on personalized medicine and precision healthcare, there is a growing demand for tailored treatment approaches in the angioedema market, presenting lucrative opportunities for market players to introduce new products and expand their market presence.
The Global Angioedema Market faces several challenges, including limited awareness about the condition among healthcare professionals and the general population, leading to underdiagnosis and undertreatment. Additionally, the complexity of diagnosing angioedema due to its similarities with other conditions like allergic reactions poses a challenge. The high cost of treatment options, including medications and therapies, can also be a barrier to access for some patients. Furthermore, the lack of standardized treatment guidelines and the variability in treatment response among individuals add to the challenges in effectively managing angioedema. Overall, addressing these challenges requires concerted efforts from healthcare providers, pharmaceutical companies, and regulatory bodies to improve awareness, access to treatment, and standardization of care for patients with angioedema.
The Global Angioedema Market is primarily driven by the increasing prevalence of hereditary angioedema (HAE) and acquired angioedema (AAE) among the global population. Rising awareness about these conditions, advancements in diagnostic technologies, and increasing healthcare expenditure are also significant drivers. Moreover, the development of novel therapies and biologics for angioedema treatment, along with the growing pipeline of drug candidates, are contributing to market growth. Additionally, the expanding geriatric population, who are more prone to angioedema, and the improving healthcare infrastructure in emerging economies are further fueling market expansion. Overall, the increasing recognition of angioedema as a serious medical condition, coupled with ongoing research and development efforts, are expected to drive the Global Angioedema Market in the coming years.
Government policies related to the Global Angioedema Market vary by country, but generally aim to ensure access to affordable treatment options, promote research and development of new therapies, and improve awareness and education about the condition. Regulations may focus on drug approval processes, pricing and reimbursement mechanisms, and patient assistance programs. Additionally, governments may collaborate with healthcare providers, pharmaceutical companies, and patient advocacy groups to address gaps in care, support innovation, and enhance patient outcomes. Policymakers may also prioritize the integration of angioedema management into national healthcare strategies to optimize resources and ensure equitable access to treatment for all patients. Overall, government policies play a crucial role in shaping the landscape of the Global Angioedema Market and advancing efforts to improve the quality of life for individuals affected by this condition.
The Global Angioedema Market is anticipated to witness significant growth in the coming years, driven by increasing awareness about the condition, advancements in diagnostic technologies, and a rising prevalence of angioedema cases worldwide. The market is expected to benefit from the introduction of novel treatments and therapies, including biologics and gene therapies, which are likely to improve patient outcomes and quality of life. Additionally, collaborations between pharmaceutical companies and research institutions for the development of innovative treatment options are projected to further boost market growth. However, challenges such as high treatment costs and limited access to healthcare in certain regions may hinder market expansion to some extent. Overall, the Global Angioedema Market is poised for steady growth in the foreseeable future.
In the global angioedema market, North America holds the largest market share due to high prevalence rates and advanced healthcare infrastructure. The region also benefits from the presence of key market players and increasing investments in research and development. Europe follows closely behind, driven by a growing awareness of the condition and government initiatives to improve patient care. In Asia, the market is witnessing significant growth attributed to increasing healthcare expenditure, rising awareness about angioedema, and expanding access to treatment options. The Middle East and Africa region is also experiencing growth, supported by improving healthcare facilities and rising incidences of angioedema. Latin America, while showing moderate growth, is expected to witness an uptick due to improving healthcare infrastructure and increasing focus on rare diseases like angioedema.
Global Angioedema Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Angioedema Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Global Angioedema Market - Industry Life Cycle |
3.4 Global Angioedema Market - Porter's Five Forces |
3.5 Global Angioedema Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.8 Global Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Global Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.10 Global Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.11 Global Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Global Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Angioedema Market Trends |
6 Global Angioedema Market, 2021 - 2031 |
6.1 Global Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Angioedema Market, Revenues & Volume, By Solid Dosage Form, 2021 - 2031 |
6.1.3 Global Angioedema Market, Revenues & Volume, By Liquid Dosage Form, 2021 - 2031 |
6.2 Global Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Angioedema Market, Revenues & Volume, By Parenteral Route, 2021 - 2031 |
6.2.3 Global Angioedema Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.2.4 Global Angioedema Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.2.5 Global Angioedema Market, Revenues & Volume, By Oral Route, 2021 - 2031 |
6.3 Global Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Angioedema Market, Revenues & Volume, By Acquired Angioedema, 2021 - 2031 |
6.3.3 Global Angioedema Market, Revenues & Volume, By Idiopathic Angioedema, 2021 - 2031 |
6.3.4 Global Angioedema Market, Revenues & Volume, By Allergic Angioedema, 2021 - 2031 |
6.3.5 Global Angioedema Market, Revenues & Volume, By Drug-Induced Angioedema, 2021 - 2031 |
6.3.6 Global Angioedema Market, Revenues & Volume, By Hereditary Angioedema, 2021 - 2031 |
6.4 Global Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Angioedema Market, Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021 - 2031 |
6.4.3 Global Angioedema Market, Revenues & Volume, By Antihistamine, 2021 - 2031 |
6.4.4 Global Angioedema Market, Revenues & Volume, By Corticosteroids, 2021 - 2031 |
6.4.5 Global Angioedema Market, Revenues & Volume, By Glucocorticoids, 2021 - 2031 |
6.4.6 Global Angioedema Market, Revenues & Volume, By Adrenaline Injection, 2021 - 2031 |
6.4.7 Global Angioedema Market, Revenues & Volume, By Hereditary Angioedema Drug Class, 2021 - 2031 |
6.4.8 Global Angioedema Market, Revenues & Volume, By C1 Esterase Inhibitor, 2021 - 2031 |
6.4.9 Global Angioedema Market, Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021 - 2031 |
6.5 Global Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Angioedema Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.5.3 Global Angioedema Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.5.4 Global Angioedema Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.6 Global Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Angioedema Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 Global Angioedema Market, Revenues & Volume, By Homecare Settings, 2021 - 2031 |
6.6.4 Global Angioedema Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 North America Angioedema Market, Overview & Analysis |
7.1 North America Angioedema Market Revenues & Volume, 2021 - 2031 |
7.2 North America Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Angioedema Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Angioedema Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Angioedema Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
7.5 North America Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.6 North America Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7.7 North America Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8 North America Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Latin America (LATAM) Angioedema Market, Overview & Analysis |
8.1 Latin America (LATAM) Angioedema Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Angioedema Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Angioedema Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Angioedema Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Angioedema Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.6 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
8.7 Latin America (LATAM) Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.8 Latin America (LATAM) Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
9 Asia Angioedema Market, Overview & Analysis |
9.1 Asia Angioedema Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Angioedema Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Angioedema Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Angioedema Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Angioedema Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
9.5 Asia Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.6 Asia Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
9.7 Asia Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.8 Asia Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
10 Africa Angioedema Market, Overview & Analysis |
10.1 Africa Angioedema Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Angioedema Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Angioedema Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Angioedema Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Angioedema Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
10.5 Africa Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.6 Africa Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
10.7 Africa Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.8 Africa Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
11 Europe Angioedema Market, Overview & Analysis |
11.1 Europe Angioedema Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Angioedema Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Angioedema Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Angioedema Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Angioedema Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
11.5 Europe Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.6 Europe Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
11.7 Europe Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.8 Europe Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
12 Middle East Angioedema Market, Overview & Analysis |
12.1 Middle East Angioedema Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Angioedema Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Angioedema Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Angioedema Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Angioedema Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
12.5 Middle East Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.6 Middle East Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
12.7 Middle East Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.8 Middle East Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
13 Global Angioedema Market Key Performance Indicators |
14 Global Angioedema Market - Export/Import By Countries Assessment |
15 Global Angioedema Market - Opportunity Assessment |
15.1 Global Angioedema Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
15.4 Global Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.5 Global Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
15.6 Global Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.7 Global Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
16 Global Angioedema Market - Competitive Landscape |
16.1 Global Angioedema Market Revenue Share, By Companies, 2024 |
16.2 Global Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here